AstraZeneca and Lilly’s Alzheimer’s drug fails trial
The battle to develop a drug to treat Alzheimer’s disease has been dealt a blow following disappointing phase 3 trial…
The battle to develop a drug to treat Alzheimer’s disease has been dealt a blow following disappointing phase 3 trial…
The interim results from a phase 3 clinical trial testing DCVax®-L, a dendritic cell treatment, show increased overall survival for…
U.S. regulatory submission for patients ages 12-17 planned for third quarter 2018 A pivotal Phase 3 trial evaluating Dupixent® (dupilumab)…